Angela Colbers

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

Kenneth Kintu, Thokozile R. Malaba, Jesca Nakibuka et al. · The Lancet HIV · 2020 · 117 citations · Full text

Treatment And Prevention, Dolutegravir Versus Efavirenz, Reproductive Health +11

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

Anna Turkova, Ellen White, Avy Violari et al. · UCL Discovery (University College London) · 2021 · 102 citations

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

Angela Colbers, David Hawkins, Andrea Gingelmaier et al. · AIDS · 2012 · 74 citations · Full text

Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1–Infected Women

Stein Schalkwijk, Angela Colbers, Déborah Konopnicki et al. · Clinical Infectious Diseases · 2017 · 71 citations · Full text

Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy

Maren I. Blonk, Angela Colbers, Carmen Hidalgo-Tenorio et al. · Clinical Infectious Diseases · 2015 · 61 citations